Q1 2026 Holdings
Filed 2026-05-15 | 33 holdings | $10.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Therapeutics Corp(UTHR) | Common | 91307C102 | $1.6B | 2,630,000 | 15.3% |
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $1.2B | 5,062,500 | 11.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $951.8M | 1,818,181 | 9.4% |
| Krystal Biotech Inc(KRYS) | Common | 501147102 | $746.3M | 2,888,888 | 7.3% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $730.3M | 1,000,000 | 7.2% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $670.9M | 10,699,999 | 6.6% |
| Kymera Therapeutics Inc(KYMR) | Common | 501575104 | $622.6M | 7,474,747 | 6.1% |
| Apellis Pharmaceuticals Inc(APLS) | Common | 03753U106 | $491.7M | 12,222,222 | 4.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $454.0M | 11,430,455 | 4.5% |
| Celcuity Inc(CELC) | Common | 15102K100 | $385.2M | 3,375,000 | 3.8% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $336.0M | 5,777,777 | 3.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $316.0M | 6,555,555 | 3.1% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $300.2M | 5,695,000 | 3.0% |
| Vera Therapeutics Inc(VERA) | Common | 92337R101 | $236.9M | 5,888,888 | 2.3% |
| Revolution Medicines Inc(RVMD) | Common | 76155X100 | $228.0M | 2,344,444 | 2.2% |
| Cytokinetics Inc(CYTK) | Common | 23282W605 | $219.7M | 3,333,333 | 2.2% |
| Ocular Therapeutix Inc(OCUL) | Common | 67576A100 | $104.3M | 12,315,000 | 1.0% |
| Damora Therapeutics Inc(GLTO) | Common | 36322Q206 | $98.0M | 3,783,000 | 1.0% |
| Uniqure NV(QURE) | Common | N90064101 | $97.4M | 5,959,595 | 1.0% |
| Taysha Gene Therapies Inc(TSHA) | Common | 877619106 | $97.0M | 21,700,000 | 1.0% |
| Definium Therapeutics Inc(DFTX) | Common | 24477V105 | $94.5M | 5,000,000 | 0.9% |
| Soleno Therapeutics Inc(SLNO) | Common | 834203309 | $77.0M | 2,300,000 | 0.8% |
| Alkermes PLC(ALKS) | Common | G01767105 | $42.4M | 1,200,000 | 0.4% |
| Septerna Inc(SEPN) | Common | 81734D104 | $32.1M | 1,337,500 | 0.3% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $29.3M | 1,500,000 | 0.3% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $25.3M | 1,800,000 | 0.2% |
| Avalo Therapeutics(AVTX) | Common | 05338F306 | $21.1M | 1,410,000 | 0.2% |
| Lexeo Therapeutics Inc(LXEO) | Common | 52886X107 | $10.8M | 1,875,000 | 0.1% |
| United Therapeutics Corp(UTHR)Call | Common | 91307C102 | $10.3M | 380,000 | 0.1% |
| Whitehawk Therapeutics Inc(WHWK) | Common | 00032Q104 | $9.8M | 2,849,402 | 0.1% |
| Mannkind Corp(MNKD) | Common | 56400P706 | $5.4M | 2,200,000 | 0.1% |
| Celcuity Inc(CELC)Call | Common | 15102K100 | $3.1M | 200,000 | 0.0% |